Tango's 2.50 bid expiring 12th June, Bumi's 2.55 bid expiring 4th June, Herald halted until 3rd June, the tension is rising with deadlines approaching. Would anyone dare predict an outcome?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%